Release Date: 25/06/09 09:34 Summary: Response to ASX Price Query Price Sensitive: Yes Download Document 505.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%